Johnson & Johnson (JNJ) Increases Yet Falls Behind Market: What Investors Need to Know

Johnson & Johnson stock gained 1.1% to $270.22 but underperformed the S&P 500's 1.14% gain. The company is expected to report Q3 earnings on October 13, 2026, with projected EPS of $2.96 (up 5.71% YoY) and revenue of $25.36 billion (up 5.71% YoY). However, JNJ trades at a premium valuation with a Forward P/E of 23.05 versus the industry average of 15.67, and holds a Zacks Rank of #3 (Hold).